| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 674.892 | 94 |
| GSM780708 | Untreated after 4 days (C2_1) | 573.594 | 92 |
| GSM780709 | Untreated after 4 days (C3_1) | 539.117 | 92 |
| GSM780719 | Untreated after 4 days (C1_2) | 654.607 | 93 |
| GSM780720 | Untreated after 4 days (C2_2) | 560.472 | 92 |
| GSM780721 | Untreated after 4 days (C3_2) | 520.111 | 92 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 437.447 | 91 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 606.462 | 93 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 613.033 | 93 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 484.8 | 91 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 665.88 | 93 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 648.859 | 93 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 627.998 | 93 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 561.364 | 92 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 685.984 | 94 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 597.503 | 93 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 592.73 | 93 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 613.732 | 93 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 687.405 | 94 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 658.033 | 93 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 555.902 | 92 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 680.933 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 590.87 | 93 |